HOOKIPA Pharma Balance Sheet Health
Financial Health criteria checks 6/6
HOOKIPA Pharma has a total shareholder equity of $89.9M and total debt of $1.1M, which brings its debt-to-equity ratio to 1.2%. Its total assets and total liabilities are $161.3M and $71.5M respectively.
Key information
1.2%
Debt to equity ratio
US$1.12m
Debt
| Interest coverage ratio | n/a |
| Cash | US$117.10m |
| Equity | US$89.86m |
| Total liabilities | US$71.48m |
| Total assets | US$161.34m |
Recent financial health updates
Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?
Apr 26
Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?
Oct 01Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?
Apr 19Recent updates
Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenue Forecasts
Mar 24Need To Know: The Consensus Just Cut Its HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates For 2023
Aug 11HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Just Slashed This Year's Revenue Estimates By 17%
May 16Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?
Apr 26Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues
Nov 19HOOKIPA wins FDA nod to start clinical studies for prostate cancer therapy
Jul 25Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts
May 18Hookipa: Speculative Biotech With Key Catalysts In 2022
Mar 29Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?
Oct 01Checking Back In On HOOKIPA Pharma
Jun 22Hookipa Pharma's HB-200 shows "positive" clinical efficacy in HPV16+ cancers
Jun 08Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?
Apr 19If You Had Bought HOOKIPA Pharma (NASDAQ:HOOK) Shares A Year Ago You'd Have Earned 64% Returns
Mar 15What Kind Of Shareholders Hold The Majority In HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Shares?
Jan 22
Hookipa: Data Readouts Of 2021's HB-101, HB-201, And HB-201/-202 Hold Promising Upside
Dec 31Introducing HOOKIPA Pharma (NASDAQ:HOOK), A Stock That Climbed 55% In The Last Year
Dec 11HOOKIPA Pharma prices public offering of common stock and preferred stock
Dec 09Financial Position Analysis
Short Term Liabilities: HOOK's short term assets ($147.1M) exceed its short term liabilities ($42.0M).
Long Term Liabilities: HOOK's short term assets ($147.1M) exceed its long term liabilities ($29.5M).
Debt to Equity History and Analysis
Debt Level: HOOK has more cash than its total debt.
Reducing Debt: HOOK's debt to equity ratio has reduced from 9.9% to 1.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HOOK has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: HOOK has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 10% each year.